載入...
Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis
Chronic hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC). Covalently closed circular DNA (cccDNA) is an intermediate in the life cycle of HBV. HBV-encoded X protein (HBx), a key viral oncoprotein, can be specifically ubiquitylated by male specific lethal 2 (MSL2), which...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781749/ https://ncbi.nlm.nih.gov/pubmed/31612010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10833 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|